A single number for advocacy and communication—worldwide more than 850 million individuals have kidney diseases
Kitty J. Jager(Amsterdam University Medical Centers), Carmine Zoccali(Università Campus Bio-Medico), Mark E. Rosenberg(University of Minnesota Medical Center), Vivekanand Jha(The George Institute for Global Health), Robyn G. Langham(The University of Melbourne), Csaba P. Kövesdy(University of Tennessee Health Science Center)
Cited by 587
Related Papers
Worldwide access to treatment for end-stage kidney disease: a systematic review
|The Lancet|2015|2.3k
Obesity and Kidney Disease: Hidden Consequences of the Epidemic
|American Journal of Nephrology|2017|2.2k
Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study
|The Lancet|2001|1.1k